Register Now
Course Information

Join us for the Unpartitioned Atrioventricular Connection: From Simple to Complex: 5th Annual Advances in Congenital Heart Disease Virtual Summit

Call for Abstracts

Submission Deadline: October 1, 2020

The 5th Annual Advances in Congenital Heart Disease Summit Planning Committee invites medical professionals and trainees (including fellows, residents, and medical students) to submit clinical and/or research abstracts for consideration for the virtual poster presentation on Friday, October 16. Monetary prizes will be awarded to the top three abstracts. The lead author for each selected abstract will receive complimentary registration to the Summit.

Click here for more information on submission procedures, review process, and more.

The overall goal of this educational activity is to update participants on the morphologies of congenital anomalies, the best diagnostic modalities and interventions, and the latest guidelines and their impact outcomes, in both adults and children.

Why Attend the Live Stream?

  • Hear experts discuss techniques and standards of care in our dynamic Saturday debate session
  • Cutting-edge, fast-paced presentations on the management of patients with AVSD
  • Earn ABIM, ABP, and ABTS Maintenance of Certification Points
  • Specialized imaging workshop
  • Participate in the abstract competition and virtual poster session
  • Explore our virtual exhibit hall

After completing this live stream activity, participants will be able to:

  • Summarize the evidence on atrioventricular septal defects (AVSD) fundamentals including morphology, imaging, and role of genetics.
  • List the pros and cons of surgical repair of complete AVSD, especially combined with other anomalies.
  • Summarize current data on complete AVSD from large cohort studies.
  • Describe the current knowledge of the single ventricle defect in AVSD, repair options, and outcomes.
  • Describe strategies for long-term assessment and management of AVSD in adults.

Who Should Attend?

The Summit is targeted to anesthesiologists, cardiologists, critical care physicians, cardiothoracic surgeons, pediatricians, OB-GYNs, perfusionists, and other health care providers interested in congenital heart disease.